Chef Anahita Naderi

CSA Medical announces closing of $16 million Series C financing CSA Medical.

We are impressed with the initial mechanism of action behind liquid nitrogen spray cryotherapy and the extensive work that CSA Medical offers underway to develop new applications. The effectiveness of the technology and administration team, combined with our limited partners' expertise mainly because leading healthcare providers, get this to a highly attractive investment opportunity for us. CSA Medical, Inc.. CSA Medical announces closing of $16 million Series C financing CSA Medical, Inc., the leading supplier of advanced spray cryotherapy technology that flash freezes undesirable tissue in the physical body, today announced that it has closed a $16 million Series C financing led by Ascension Ventures .We wish the success of the first two projects will inspire others to aid this initiative, so we are able to fund additional promising precision medicine projects to greatly help patients. A team led by David Haussler, PhD, a professor of biomolecular engineering at UC Santa Cruz, and Theodore Goldstein, PhD, a study associate at UC Santa Cruz, will develop a secure Internet-based networking program to complement cancer therapies to specific children predicated on the genetic characteristics of their tumors.